60 related articles for article (PubMed ID: 12133326)
1. [The expression of erbB/HER family in lung cancer].
Deng Z; Ge D; Zhang D; Tan Y; Bai C; Xu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Apr; 25(4):207-9. PubMed ID: 12133326
[TBL] [Abstract][Full Text] [Related]
2. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
Yi ES; Harclerode D; Gondo M; Stephenson M; Brown RW; Younes M; Cagle PT
Mod Pathol; 1997 Feb; 10(2):142-8. PubMed ID: 9127320
[TBL] [Abstract][Full Text] [Related]
3. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
Zhang Y; Sun Y; Li Y; Fang Z; Wang R; Pan Y; Hu H; Luo X; Ye T; Li H; Wang L; Chen H; Ji H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S577-82. PubMed ID: 23775406
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
[TBL] [Abstract][Full Text] [Related]
5. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma].
Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079
[TBL] [Abstract][Full Text] [Related]
6. C-erbB-3 expression in non-small cell lung cancer (NSCLC) patients treated by Erlotinib.
CsToth I; Anthoine G; Berghmans T; Mascaux C; Paesmans M; Sculier JP; Meert AP
Anticancer Res; 2011 Jan; 31(1):281-5. PubMed ID: 21273611
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M
J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604
[TBL] [Abstract][Full Text] [Related]
8. Correlation of c-erbB-2, EGF and EGFR expression with postoperative survival of patients with advanced carcinoma of the stomach.
Czyzewska J; Guzinska-Ustymowicz K; Kemona A
Folia Histochem Cytobiol; 2009; 47(4):653-61. PubMed ID: 20430735
[TBL] [Abstract][Full Text] [Related]
9. [Expression of epidermal growth factor receptor (EGFR), platelet growth factor receptor (PGFR) and insulin growth factor-1 receptor (IGF-1R) on lung cancer cell].
Liu S; Zhang B; Zhang S
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Dec; 21(12):733-4. PubMed ID: 11480076
[TBL] [Abstract][Full Text] [Related]
10. [Expression of PKB protein in human squamous-cell carcinoma and adenocarcinoma of lung].
Liao YD; Long QH; Zhou S; Zhao JP; Huang Q; Fu XN
Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):156-9. PubMed ID: 15946565
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the C-erbB-2 expression in turkish non-small cell lung cancer patients.
Calikusu Z; Yildirim Y; Akcali Z; Sakalli H; Bal N; Ozyilkan O
Asian Pac J Cancer Prev; 2009; 10(3):479-82. PubMed ID: 19640195
[TBL] [Abstract][Full Text] [Related]
12. Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma.
Yanagawa N; Leduc C; Kohler D; Saieg MA; John T; Sykes J; Yoshimoto M; Pintilie M; Squire J; Shepherd FA; Tsao MS
J Thorac Oncol; 2012 Oct; 7(10):1513-21. PubMed ID: 22982652
[TBL] [Abstract][Full Text] [Related]
13. HER-2 overexpression (3+) in patients with squamous cell esophageal carcinoma correlates with poorer survival.
Dreilich M; Wanders A; Brattström D; Bergström S; Hesselius P; Wagenius G; Bergqvist M
Dis Esophagus; 2006; 19(4):224-31. PubMed ID: 16866851
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patients.
Al-Saad S; Al-Shibli K; Donnem T; Andersen S; Bremnes RM; Busund LT
J Thorac Oncol; 2010 Oct; 5(10):1536-43. PubMed ID: 20802349
[TBL] [Abstract][Full Text] [Related]
15. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
[TBL] [Abstract][Full Text] [Related]
16. RET finger protein expression is associated with prognosis in lung cancer with epidermal growth factor receptor mutations.
Iwakoshi A; Murakumo Y; Kato T; Kitamura A; Mii S; Saito S; Yatabe Y; Takahashi M
Pathol Int; 2012 May; 62(5):324-30. PubMed ID: 22524660
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous expression of c-erbB-1, c-erbB-2, c-erbB-3 and c-erbB-4 receptors in non-small-cell lung carcinomas: correlation with clinical outcome.
Koutsopoulos AV; Mavroudis D; Dambaki KI; Souglakos J; Tzortzaki EG; Drositis J; Delides GS; Georgoulias V; Stathopoulos EN
Lung Cancer; 2007 Aug; 57(2):193-200. PubMed ID: 17442448
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of type 1 growth factor receptor expression in colon cancer.
Leung SP; Griffith OL; Masoudi H; Gown A; Jones S; Phang T; Wiseman SM
Am J Surg; 2008 May; 195(5):604-10. PubMed ID: 18424279
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.
Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103
[TBL] [Abstract][Full Text] [Related]
20. Identification of flotillin-1 as a novel biomarker for lymph node metastasis and prognosis of lung adenocarcinoma by quantitative plasma membrane proteome analysis.
Zhang PF; Zeng GQ; Hu R; Li C; Yi H; Li MY; Li XH; Qu JQ; Wan XX; He QY; Li JH; Chen Y; Ye X; Li JY; Wang YY; Feng XP; Xiao ZQ
J Proteomics; 2012 Dec; 77():202-14. PubMed ID: 22982323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
